BDNF and schizophrenia: Vasconcelos et al. observed that this reduction in BDNF is related to an increase in oxidative stress in schizophrenic patients, as the administration of alpha-lipoic acid, a drug that counteracts free radicals, increases BDNF and improves cognitive capacities in animal models of schizophrenia [41].